| Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673) |
|---|
| 10/25/2007 | US20070247063 Light-Emitting Device Material and Light-Emitting Device |
| 10/24/2007 | EP1847263A2 Inhibitors against the production and release of inflammatory cytokines |
| 10/24/2007 | EP1846392A2 Heterocyclic triazines as hypoxic selective protein kinase inhibitors |
| 10/24/2007 | EP1845779A1 Anti-bacterial compounds |
| 10/24/2007 | EP1112743B1 Nitrogenous heterocyclic carboxamide derivatives or salt thereof as antiviral agents |
| 10/24/2007 | CN101061098A Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors |
| 10/24/2007 | CN101058564A Aryl alkyl carbamate derivatives production and use thereof in therapy |
| 10/23/2007 | US7285568 Substituted p-(2-alkoxy-2-acylethyl)biphenyl compounds, e.g., 1-[4'-(2-ethoxy-3-morpholin-4-yl-3-oxopropyl)biphenyl-3-yl]-3-heptyl-1-methylurea; useful in human or veterinary medicine: dermatology, cardiovascular diseases, immune diseases, and diseases associated with lipid metabolism |
| 10/23/2007 | US7285553 Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders |
| 10/18/2007 | WO2007117180A1 Azaheterocycles, combinatory library, focused library, pharmaceutical composition and methods for the production thereof |
| 10/18/2007 | WO2007116374A1 Novel sulfonamide compounds |
| 10/18/2007 | WO2007116314A1 N-phenyl-1,1,1-trifluoromethanesulfonamide hydrazone derivative compounds and their usage in controlling parasites |
| 10/18/2007 | WO2007115968A2 Process for the preparation of a glucokinase activator |
| 10/18/2007 | WO2007115967A1 Crystalline isopropanol solvate of glucokinase activator |
| 10/18/2007 | WO2007077543A3 Sigma-2 receptor, method of screening of specific ligands and use of the same in diagnostic or therapeutic methods |
| 10/18/2007 | US20070244197 Bactericide against gramnegative bacteria; respiratory system disorders |
| 10/18/2007 | US20070244129 Process for the preparation of an isopropanol solvate of a glucokinase activator |
| 10/18/2007 | US20070244124 For therapy of multi-drug resistant disease; combination therapy; anticarcinogenic agent; leukemia; hydrochloride salt; obtained with copper radiation source |
| 10/18/2007 | US20070244122 Derivatives of sulindac, use thereof and preparation thereof |
| 10/18/2007 | US20070244108 Phenylsulfonamide Derivatives for Use as 11-Beta-Hydroxysteroid Dehydrogenase Inhibitors |
| 10/18/2007 | US20070243416 Amine Compound and Organic Electroluminescent Element Employing the Same |
| 10/18/2007 | US20070241667 Light Emitting Element and Light Emitting Device |
| 10/18/2007 | CA2648978A1 N-phenyl-1,1,1-trifluoromethanesulfonamide hydrazone derivative compounds and their usage in controlling parasites |
| 10/18/2007 | CA2646917A1 Novel sulfonamide compounds |
| 10/17/2007 | EP1844766A2 Inhibitors against the production and release of inflammatory cytokines |
| 10/17/2007 | CN100343285C Heterocyclic alkoxyl amine as regulator in controlled free radical polymerization method |
| 10/17/2007 | CN100343249C 2,4,4-trisubstituted-1,3-dioxolane antifungals |
| 10/17/2007 | CN100343240C Stereoselective alkylation of chiral 2-methyl-4-protected piperazines |
| 10/16/2007 | US7282608 Inhibitors of histone deacetylase |
| 10/16/2007 | US7282511 Isatine derivatives with neurotrophic activity |
| 10/11/2007 | WO2007089335A3 Multicyclic amino acid derivatives and methods of their use |
| 10/11/2007 | WO2000072801A3 Alpha v integrin receptor antagonists |
| 10/11/2007 | US20070238735 Cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 10/11/2007 | DE60022050C5 Metabotrope glutamatrezeptorantagonisten zur behandlung von krankheiten des zentralen nervensystems Metabotropic glutamate receptor antagonists for treating diseases of the central nervous system |
| 10/10/2007 | EP1841730A1 Cathepsin k inhibitors and atherosclerosis |
| 10/10/2007 | EP1756119B1 Collection of traceable compounds and uses thereof |
| 10/10/2007 | CN101052625A Adamantyl derivates as p2x7 receptor antagonists |
| 10/09/2007 | US7279593 Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders |
| 10/09/2007 | US7279582 For example (2S, 3S, 5S)-2-(2,6-dimethylphenoxyacetyl)amino-3-hydroxy-5-(2S-(1-tetrahydro-pyrimid-2-onyl)-3-methyl butanoyl)amino-1,6-diphenylhexane; HIV therapy |
| 10/09/2007 | US7279493 cyanoiminopiperazines which inhibit vanilloid receptor 1 function in a cell |
| 10/09/2007 | US7279478 Cathepsin cysteine protease inhibitors |
| 10/09/2007 | US7279470 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 10/04/2007 | WO2007112347A1 Dipeptidyl peptidase inhibitors |
| 10/04/2007 | WO2007049158A3 Ppar modulating biaromatic compounds |
| 10/04/2007 | US20070232768 Alkoxyamines Containing a Radically Polymerizable Group |
| 10/04/2007 | US20070232618 Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands |
| 10/04/2007 | US20070232614 Therapeutic Agent for Nonviral Hepatitis |
| 10/04/2007 | US20070232601 Vla-4 Inhibitor |
| 10/03/2007 | EP1448530B1 Heteroaryl carboxylic acid amides |
| 10/03/2007 | CN101048390A Heterocyclical chromophore architectures |
| 10/03/2007 | CN101048389A Heterocyclical anti-aromatic chromophore architectures |
| 10/02/2007 | US7276612 For hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(benzofuran-, benzothiophen-, or indol-)-2-ylcarbonylamino]alkoxy}benzamides |
| 10/02/2007 | CA2096407C Retroviral protease inhibitors |
| 09/27/2007 | WO2007109175A1 N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors |
| 09/27/2007 | WO2007108483A1 N-2-(hetero)arylethylcarboxamide derivative, and pest-controlling agent comprising the same |
| 09/27/2007 | WO2007108403A1 Quinoxaline derivative, and light-emitting element, light-emitting device, electronic device using the quinoxaline derivative |
| 09/27/2007 | US20070225372 Amides as Bace Inhibitors |
| 09/27/2007 | US20070225294 2-[4-({[4-{[4-(4-acetylphenyl)-1-piperazinyl]methyl}-2-(4-fluorophenyl)-1,3-thiazol-5-yl]methyl}sulfanyl)-2-methylphenoxy]-2-methylpropanoic acid; dyslipidemia, syndrome X, hypercholesteremia, type II diabetes mellitus, type I diabetes, insulin resistance, hyperlipidemia, and obesity |
| 09/27/2007 | US20070225292 Therapeutic Compounds: Pyridine as Scaffold |
| 09/27/2007 | US20070225287 Substituted Arylpyrazines |
| 09/27/2007 | US20070222374 N,N',N'-triphenyl-N-[4-(3-phenylquinoxalin-2-yl)phenyl]benzene-1,4-diamine; bipolar, thermostability; light emiiting diodes with low driving voltage and low power consumption and high luminous efficiency |
| 09/27/2007 | CA2645434A1 Benzoimidazolyl-parazine compounds for inflammation and immune-related uses |
| 09/26/2007 | EP1836179A1 Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase |
| 09/26/2007 | EP1836175A2 Fluorescent pyrazine derivatives and methods of using the same in assessing renal function |
| 09/26/2007 | EP1276732B1 Amides of r-2-(aminoaryl)-propionic acids for use in theprevention of leucocyte activation" |
| 09/26/2007 | CN101044125A Heterocyclic compounds and methods of use |
| 09/26/2007 | CN101044115A Piperidines and related compounds for treatment of alzheimer's disease |
| 09/26/2007 | CN101041640A Antineoplastic active substance of diketopiperazine PJ147and PJ157 |
| 09/26/2007 | CN100339354C Process for the preparation of chiral beta amino acid derivatives by asymmetric hydrogenation |
| 09/25/2007 | US7273952 Substituted C-cyclohexylmethylamine derivatives |
| 09/25/2007 | US7273946 Nitroxy derivatives, e.g., 4-(nitrooxy)butyl [1R-[1 alpha (Z),2 alpha (R*),3 alpha ,5 alpha ]]-7-[3,5-dihydroxy-2-(3-hydroxy-5-phenylpentyl)cyclopentyl]-5-heptenoate; used for the treatment of glaucoma and ocular hypertension |
| 09/25/2007 | US7273878 Difluoroalkene derivative, pest control agent containing the same, and intermediate therefor |
| 09/25/2007 | US7273869 P-(aminomethyl)phenyl-substituted pyrazoloquinoxalines, imidazoquinoxalines, triazoloquinoxalines and benzoquinoxalines, e.g., N,N-dimethyl-1-[4-(6-phenyl-1H-imidazo[4,5-g]quinoxalin-7-yl)phenyl]methanamine; serine/threonine protein kinase inhibitors for treating cancer |
| 09/25/2007 | US7273867 Anticaogulants; cardiovascular disorders; Factor x inhibitors; antiinflammatory agents |
| 09/25/2007 | US7273863 Benzophenones as inhibitors of reverse transcriptase |
| 09/25/2007 | CA2245701C Mixtures derived from grains of eugenia jambolana lamarck, preparation and use of said mixtures and some of their constituents as medicaments |
| 09/20/2007 | WO2007105766A1 Novel 1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity |
| 09/20/2007 | WO2007105023A1 Modulation of phosphoryl transferase activity of glutamine synthetase |
| 09/20/2007 | WO2007104144A1 Compounds, ionic liquids, molten salts and uses thereof |
| 09/20/2007 | US20070219372 Novel Amination Process |
| 09/20/2007 | US20070219280 Organometallic Complex Structure and Production Method Thereof; and Functional Film, Functional Composite Material, Functional Structure and Adsorption and Desorption Sensor Using the Organometallic Complex Structure |
| 09/20/2007 | US20070219215 Thioamides and Salts Thereof and Cytokine Production Inhibitors Containing Both |
| 09/20/2007 | US20070219214 Dual NK2/NK3-antagonists, pharmaceutical compositions comprising them, and processes for their preparation |
| 09/20/2007 | US20070219213 Use of Adrenergic N-Phenylpiperazine Antagonists, Pahrmaceutical Compositions Containning Them, and Methods of Preparing Them |
| 09/20/2007 | US20070219202 3-(2-alkoxycarbonyl-3-indolyl)-3-oxo-propionic acid ester or propionamide intermediates: methyl 3-[6-fluoro-2-(methoxycarbonyl)-1-methyl-1H-indol-3-yl]-3-oxopropanoate; peripheral neuropathy, Parkinson's disease, Alzheimer's disease |
| 09/20/2007 | CA2645456A1 Photoactive compounds and compositions and uses thereof |
| 09/20/2007 | CA2643070A1 Novel 1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity |
| 09/19/2007 | EP1833796A1 Indenyl derivatives and use thereof for the treatment of neurological disorders |
| 09/19/2007 | CN101037416A 2,5,6-three substitution pyrazine derivatives |
| 09/19/2007 | CN100337751C Hydroxylation of beta-dicarbonyls with zirconium catalysts |
| 09/18/2007 | CA2275764C Process for the preparation of heteroaryl-phenylalanines |
| 09/13/2007 | US20070213534 Process for the Manufacture of fused piperazin-2-one derivatives |
| 09/13/2007 | US20070213528 Process for the Manufacture of Fused piperazin-2-one derivatives |
| 09/13/2007 | US20070213333 Suppress production of both prostaglandins and leukotrienes and have reduced side effects; treatment of various inflammatory diseases, autoimmune diseases, allergic diseases, pain and fibrosis; for example, methyl 3-[3-acetylamino-4-cyclopentyloxy-5-(naphthalen-2-yl)phenyl]propionate |
| 09/13/2007 | US20070213331 Beta -secretase (BACE); Alzheimer's disease; 2-(R)-[2-(S)-Amino-3-(3,5-difluorophenyl)-1-(S)-hydroxypropyl]-pyrrolidine-1-carboxylic acid tert-butyl ester |
| 09/13/2007 | US20070213329 Sulphones which modulate the action of gammasecretase |
| 09/13/2007 | US20070213323 Novel pyridinone derivatives and their use as positive allosteric modulators of mglur2-receptors |
| 09/13/2007 | US20070213316 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 09/13/2007 | CA2644494A1 Processes for synthesizing 7-alkynyl-4-aminoquinazolines and a related intermediate |
| 09/12/2007 | EP1831184A2 Pyrazines and pyridines and derivatives thereof as therapeutic compounds |